Brentuximab vedotin in a patient with enteropathy-associated T‑cell lymphoma of the small bowel
Crossref DOI link: https://doi.org/10.1007/s12254-017-0312-x
Published Online: 2017-02-06
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haslbauer, Ferdinand http://orcid.org/0000-0002-1635-3260
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
License valid from 2017-02-06